These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 22125235)

  • 1. Combined implantation of CD34+ and CD14+ cells increases neovascularization through amplified paracrine signalling.
    Krenning G; van der Strate BW; Schipper M; Brouwer LA; Fernandes BC; van Luyn MJ; Harmsen MC
    J Tissue Eng Regen Med; 2013 Feb; 7(2):118-28. PubMed ID: 22125235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating human CD34+ progenitor cells modulate neovascularization and inflammation in a nude mouse model.
    van der Strate BW; Popa ER; Schipper M; Brouwer LA; Hendriks M; Harmsen MC; van Luyn MJ
    J Mol Cell Cardiol; 2007 Jun; 42(6):1086-97. PubMed ID: 17490680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly angiogenic CXCR4(+)CD31(+) monocyte subset derived from 3D culture of human peripheral blood.
    Hur J; Choi JI; Yun JY; Yoon CH; Jang JH; Im SG; Ko SB; Kang JA; Park J; Lee SE; Kim JY; Yang HM; Park YB; Kim HS
    Biomaterials; 2013 Mar; 34(8):1929-41. PubMed ID: 23267826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential healing activities of CD34+ and CD14+ endothelial cell progenitors.
    Awad O; Dedkov EI; Jiao C; Bloomer S; Tomanek RJ; Schatteman GC
    Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):758-64. PubMed ID: 16410458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases.
    Yoon CH; Hur J; Park KW; Kim JH; Lee CS; Oh IY; Kim TY; Cho HJ; Kang HJ; Chae IH; Yang HK; Oh BH; Park YB; Kim HS
    Circulation; 2005 Sep; 112(11):1618-27. PubMed ID: 16145003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating CD34+ progenitor cells modulate host angiogenesis and inflammation in vivo.
    Popa ER; Harmsen MC; Tio RA; van der Strate BW; Brouwer LA; Schipper M; Koerts J; De Jongste MJ; Hazenberg A; Hendriks M; van Luyn MJ
    J Mol Cell Cardiol; 2006 Jul; 41(1):86-96. PubMed ID: 16780869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular-specific quantification in an in vivo Matrigel chamber angiogenesis assay.
    Baker JH; Huxham LA; Kyle AH; Lam KK; Minchinton AI
    Microvasc Res; 2006 Mar; 71(2):69-75. PubMed ID: 16545400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paracrine effects of CD34 progenitor cells on angiogenic endothelial sprouting.
    Scheubel RJ; Holtz J; Friedrich I; Borgermann J; Kahrstedt S; Navarrete Santos A; Silber RE; Simm A
    Int J Cardiol; 2010 Mar; 139(2):134-41. PubMed ID: 19008002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel vasculo-angiogenic effect of cilostazol mediated by cross-talk between multiple signalling pathways including the ERK/p38 MAPK signalling transduction cascade.
    Chao TH; Tseng SY; Li YH; Liu PY; Cho CL; Shi GY; Wu HL; Chen JH
    Clin Sci (Lond); 2012 Aug; 123(3):147-59. PubMed ID: 22339730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD34- blood-derived human endothelial cell progenitors.
    Harraz M; Jiao C; Hanlon HD; Hartley RS; Schatteman GC
    Stem Cells; 2001; 19(4):304-12. PubMed ID: 11463950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells.
    Urbich C; Heeschen C; Aicher A; Dernbach E; Zeiher AM; Dimmeler S
    Circulation; 2003 Nov; 108(20):2511-6. PubMed ID: 14581410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial differentiation potential of human monocyte-derived multipotential cells.
    Kuwana M; Okazaki Y; Kodama H; Satoh T; Kawakami Y; Ikeda Y
    Stem Cells; 2006 Dec; 24(12):2733-43. PubMed ID: 16888284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth factor supplemented matrigel improves ectopic skeletal muscle formation--a cell therapy approach.
    Barbero A; Benelli R; Minghelli S; Tosetti F; Dorcaratto A; Ponzetto C; Wernig A; Cullen MJ; Albini A; Noonan DM
    J Cell Physiol; 2001 Feb; 186(2):183-92. PubMed ID: 11169455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bcr-abl-positive cells secrete angiogenic factors including matrix metalloproteinases and stimulate angiogenesis in vivo in Matrigel implants.
    Janowska-Wieczorek A; Majka M; Marquez-Curtis L; Wertheim JA; Turner AR; Ratajczak MZ
    Leukemia; 2002 Jun; 16(6):1160-6. PubMed ID: 12040448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient nonadhesive ex vivo expansion of early endothelial progenitor cells derived from CD34+ human cord blood fraction for effective therapeutic vascularization.
    O E; Lee BH; Ahn HY; Shin JC; Kim HK; Kim M; Park IY; Park YG; Joe YA
    FASEB J; 2011 Jan; 25(1):159-69. PubMed ID: 20852063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered human tumor xenografts with functional human vascular networks.
    Alonso-Camino V; Santos-Valle P; Ispizua MC; Sanz L; Alvarez-Vallina L
    Microvasc Res; 2011 Jan; 81(1):18-25. PubMed ID: 20934439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FGF2-dependent neovascularization of subcutaneous Matrigel plugs is initiated by bone marrow-derived pericytes and macrophages.
    Tigges U; Hyer EG; Scharf J; Stallcup WB
    Development; 2008 Feb; 135(3):523-32. PubMed ID: 18171688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosomes from human CD34(+) stem cells mediate their proangiogenic paracrine activity.
    Sahoo S; Klychko E; Thorne T; Misener S; Schultz KM; Millay M; Ito A; Liu T; Kamide C; Agrawal H; Perlman H; Qin G; Kishore R; Losordo DW
    Circ Res; 2011 Sep; 109(7):724-8. PubMed ID: 21835908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD34+ cells augment endothelial cell differentiation of CD14+ endothelial progenitor cells in vitro.
    Krenning G; Strate BWAV; Schipper M; van Seijen XJGY; Fernandes BCA; van Luyn MJA; Harmsen MC
    J Cell Mol Med; 2009 Aug; 13(8B):2521-2533. PubMed ID: 18752636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of VEGF165 by Ewing's sarcoma cells induces vasculogenesis and the incorporation of CD34+ stem cells into the expanding tumor vasculature.
    Lee TH; Bolontrade MF; Worth LL; Guan H; Ellis LM; Kleinerman ES
    Int J Cancer; 2006 Aug; 119(4):839-46. PubMed ID: 16557578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.